http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Jun 2026 18:07:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce the closing of the previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for cash consideration of $<b>0.80</b> per Share (the “<b>Consideration</b>”). </p><p> The Company’s Shares will be delisted from the Toronto Stock Exchange (“<b>TSX</b>”) and the Company will apply to the applicable Canadian securities regulators to cease to be http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Closing+of+Arrangement/26600688.html Wed, 03 Jun 2026 18:07:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX</b> <b>and OTC US: CRRTF) </b>(<b>“Crescita” </b>or the “<b>Company</b>”) is pleased to announce that holders of the issued and outstanding common shares (the “<b>Shares</b>”) of the Company (each a “<b>Shareholder</b>”) will be entitled to receive $0.80 per Share (subject to any applicable withholdings) (the “<b>Consideration</b>”) under its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all the Shares in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Announces+Final+Consideration+Payable+to+Shareholders+Pursuant+to+Arrangement+with+ClinActiv/26585712.html Mon, 01 Jun 2026 20:59:00 -0400 A.14440365 CRRTF CTX O.28773626 O.36953541 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement dated March 14, 2026 (the http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html Wed, 20 May 2026 17:07:00 -0400 CRRTF CTX O.28773626 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement dated March 14, 2026 (the http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html Wed, 20 May 2026 17:07:00 -0400 CRRTF CTX O.28773626 http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement dated March 14, 2026 (the http://www.streetinsider.com/Press+Releases/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html Wed, 20 May 2026 17:07:00 -0400 CRRTF CTX O.28773626 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement dated March 14, 2026 (the http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html Wed, 20 May 2026 17:07:00 -0400 CRRTF CTX O.28773626 http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html <p> LAVAL, Québec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. <b>(TSX: CTX and OTC US: CRRTF)</b> (“<b>Crescita</b>” or the “<b>Company</b>”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “<b>Arrangement</b>”) with ClinActiv Holdings Inc. (“<b>ClinActiv</b>”) and its wholly-owned subsidiary (the “<b>Purchaser</b>”), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “<b>Shares</b>”) in exchange for all-cash consideration, subject to the terms and conditions of the arrangement agreement dated March 14, 2026 (the http://www.streetinsider.com/Business+Wire/Crescita+Therapeutics+Inc.+Obtains+Final+Order+Approving+Plan+of+Arrangement/26529439.html Wed, 20 May 2026 17:07:00 -0400 CRRTF CTX O.28773626